THE EFFECT OF AROMATHERAPY FOOT BATHS ON CANCER PATIENTS
ConditionPatients Diagnosed With Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara Yildirim Beyazıt University
About this trial
The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question\[s\] it aims to answer are:
* Is an aromatherapy foot bath effective in reducing pain in cancer patients? * Is an aromatherapy foot bath effective in improving sleep quality in cancer patients? * Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 18 years of age,
Conscious (Glasgow coma scale: 15 points)
No diagnosis of mental illness
No respiratory distress
Disqualifiers
Patients under 18 years of age,
Patients with a Glasgow Coma Scale score below 15 points,
Patients with a diagnosis of mental illness,
Patients with respiratory distress,
Trial design
Design model
Parallel
Treatments tested in this trial
Aromatherapy
Other interventionThe experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water.
Treatment groups
70 Participants
are divided into 2 treatment groupsGroup A: Aromatherapy GroupExperimental treatment 1 intervention
Group B: Standard Care GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Hirai Cancer Fatigue Scale
The scale has a minimum score of 15 and a maximum score of 75. Higher scores indicate increased fatigue, while lower scores indicate decreased fatigue.
Time frame
Baseline and day 52
Numerical Pain Scale
Participants will be asked to rate the intensity of their pain on a scale of 0 (no pain) to 10 (most severe pain). A higher score indicates increasing pain.
Time frame
Baseline and day 53
Pittsburgh Sleep Quality Index
The total score ranges from 0 to 21. A total score higher than 5 indicates poor sleep quality.
Time frame
Baseline and day 5Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: